Your session is about to expire
← Back to Search
Dietary Supplement
Nutritional Snacks for Dementia
N/A
Recruiting
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Has a medical diagnosis of dementia or possible dementia
Be older than 18 years old
Must not have
Requires 100% feeding assistance
Cannot participate in the protocol independently and do not have a consistent caregiver who can provide assistance
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8)
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether or not a new type of snack food, which starts as one texture and changes to another, can help improve the nutritional intake of adults with dementia.
Who is the study for?
This trial is for stable adults living at home with a medical diagnosis of dementia or possible dementia. They must be able to participate in the study protocol on their own or have a caregiver who can assist, and they need smartphone access. People who require full feeding assistance, are NPO (nothing by mouth), have multiple food allergies, or need strict renal, low-fat/no-salt diets cannot join.
What is being tested?
The study tests if transitional-state snacks—foods that change texture—can improve nutrition in people with dementia. These savory snacks resemble regular foods and aim to enhance physical and cognitive health by improving dietary intake.
What are the potential side effects?
While specific side effects aren't listed, potential risks may include choking hazards or allergic reactions if participants react to snack ingredients. Safety will be monitored closely given the vulnerability of individuals with dementia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with dementia.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I need help with all my feeding.
Select...
I can participate on my own or have a caregiver to assist me.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in acceptability of nutrition supplements
Number of test snacks consumed each week
Participant enrollment rates (%)
+2 moreSecondary study objectives
Change in calcium intake (mg/d)
Change in carbohydrate intake (g/d)
Change in daily energy intake (kcal/d)
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Intervention ArmExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Oregon Partnership for Alzheimer's ResearchUNKNOWN
1 Previous Clinical Trials
3 Total Patients Enrolled
University of OregonLead Sponsor
85 Previous Clinical Trials
44,218 Total Patients Enrolled
1 Trials studying Dementia
250 Patients Enrolled for Dementia
Oregon Health and Science UniversityOTHER
1,006 Previous Clinical Trials
7,413,899 Total Patients Enrolled
13 Trials studying Dementia
1,483 Patients Enrolled for Dementia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My health condition is currently stable.A speech therapist has advised against certain foods for me.I need help with all my feeding.I have been diagnosed with dementia.I can participate on my own or have a caregiver to assist me.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger